Beijing Foyou Pharma (601089.SH): Hydrobromide Xylitol Oral Solution Obtained Drug Registration Certificate

15:53 10/02/2026

Fuyuan Pharmaceutical (601089.SH) announced that recently, its wholly-owned subsidiary Fuyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Fuyuan") received the "Drug Registration Certificate" for the oral solution of brompheniramine maleate (specification: 200ml:160mg) (hereinafter referred to as "the drug") issued by the National Medical Products Administration (NMPA), approving the production of the drug.

Beijing Foyou Pharma (601089.SH) released an announcement, stating that recently, its wholly-owned subsidiary, Anhui Fuyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Fuyuan"), received the "Drug Registration Certificate" (Certificate Number: 2026S00394) issued by the National Medical Products Administration for the bromhexine hydrochloride oral solution (specification: 200ml:160mg) (hereinafter referred to as "the drug"), approving the production of the drug.

New Stock News | 4068 times! SeaTech Technology (02706) completely ignites the new stock market, creating a new record in Hong Kong stocks AI subscription for the year

ZHONG JIA GX (00899): Wang Zuwei appointed as non-executive director

Semiconductor Manufacturing International Corporation (00981) released its fourth-quarter performance, with sales revenue of $2.489 billion, representing a 4.5% increase compared to the previous quarter. The gross profit margin is 19.2%.

New Stock News | 4068 times! SeaTech Technology (02706) completely ignites the new stock market, creating a new record in Hong Kong stocks AI subscription for the year

ZHONG JIA GX (00899): Wang Zuwei appointed as non-executive director